← Back to Search

Suicide Prevention Interventions for Suicidal Thoughts in Young Adults

N/A
Recruiting
Led By Elizabeth Arnold, PhD
Research Sponsored by Elizabeth Arnold
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and months 1, 3, 6, 9, and 12
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to reduce suicide among young people by testing two short online programs. These programs are designed to help reduce suicidal thoughts and will be delivered through primary care clinics in Texas.

Who is the study for?
This trial is for sexual and gender diverse young adults aged 18-24 in Texas who speak English, have not had mental health services (except medication/case management) in the past 90 days, and are at risk of suicide.
What is being tested?
The study aims to reduce suicide by comparing two telehealth interventions adapted for sexual and gender diverse youth: YST-III vs. STAT-PC. Clinics will be randomly chosen to use one of these methods with participants.
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, side effects may include emotional discomfort or distress during or after sessions but are generally considered low-risk.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and months 1, 3, 6, 9, and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and months 1, 3, 6, 9, and 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in suicidal ideation as measured by the Adult Suicidal Ideation Questionnaire (ASIQ)
Secondary study objectives
Change in depressive symptoms as measured by Center for Epidemiologic Studies Depression Scale-Revised CESD-R
Change in internalized stigma as measured by Internalized Transphobia Scale (ITS)-adapted
Change in number of mental healthcare service utilization as measured by Emergency Department Screen for Teens at Risk for Suicide (ED-STARS) mental health service utilization check list
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Youth-Nominated Support Team (YST-III)Experimental Treatment1 Intervention
This group will participate in a brief, suicide prevention intervention originally developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation that has been adapted.
Group II: Suicidal Teens Accessing Treatment - Primary Care (STAT-PC)Experimental Treatment1 Intervention
This group will participate in a brief, suicide prevention intervention based on motivational interviewing that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management that has been adapted.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for suicide prevention, especially for sexual and gender diverse youth, include cognitive-behavioral therapy (CBT) and other brief interventions delivered via telehealth. These treatments work by helping patients identify and change negative thought patterns, develop coping strategies, and build a support network. The telehealth delivery method increases accessibility and convenience, which is crucial for reaching at-risk populations who may face barriers to in-person care. By addressing the specific needs and stressors of sexual and gender diverse youth, these interventions can effectively reduce suicidal ideation and improve mental health outcomes.

Find a Location

Who is running the clinical trial?

Elizabeth ArnoldLead Sponsor
1 Previous Clinical Trials
70 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
574 Previous Clinical Trials
27,077,647 Total Patients Enrolled
Elizabeth Arnold, PhDPrincipal InvestigatorUniversity of Kentucky
2 Previous Clinical Trials
73 Total Patients Enrolled

Media Library

STAT-PC Clinical Trial Eligibility Overview. Trial Name: NCT05869552 — N/A
Adolescent Suicidality Research Study Groups: Youth-Nominated Support Team (YST-III), Suicidal Teens Accessing Treatment - Primary Care (STAT-PC)
Adolescent Suicidality Clinical Trial 2023: STAT-PC Highlights & Side Effects. Trial Name: NCT05869552 — N/A
STAT-PC 2023 Treatment Timeline for Medical Study. Trial Name: NCT05869552 — N/A
~806 spots leftby Jul 2026